Latest filing published 12 Mar 2009 for JUNIPER PHARMACEUTICALS INC, €137.
Insider track record
No signal scores available.
James Meer: trading record in brief
This profile gathers the share dealings of James Meer in Juniper Pharmaceuticals Inc. Over a trading history stretching from 28 February 2007 to 11 March 2009, the count stands at 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 12 March 2009, reports a share grant of €137 in Juniper Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Meer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,500 shares@ US$0.01$.01 Par Value Common StockSEC:0001140361-09-006803:0
- 1,400 shares@ US$1.37$.01 Par Value Common StockSEC:0001140361-09-005886:0
- 1,750 shares@ US$1.53$.01 Par Value Common StockSEC:0001140361-09-005886:1
- 4,000 shares@ US$4.26$.01 Par Value Common StockSEC:0001140361-08-017828:0
- 1,400 shares@ US$2.42$.01 Par Value Common StockSEC:0001144204-08-012998:0
- 14,000 shares@ US$0.01$.01 Par Value Common StockSEC:0001144204-07-011101:0
6 of 6 declarations